Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Isshiki

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Current Cancer Drug Targets|January 8, 2021
Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL)Yusuke Isshiki, Ari Melnick
Experimental Hematology|December 18, 2018
Emerging role of noncanonical polycomb repressive complexes in normal and malignant hematopoiesisYusuke Isshiki, Atsushi Iwama
BMJ Case Reports|December 21, 2018
Multiple cystic lung lesions and autoimmune thrombocytopaenia developing after chemotherapy for pulmonary indolent B-cell lymphoma with plasmacytic differentiationHiroaki Tanaka, Chihiro Kuwabara, Yusuke Isshiki, et al.
Experimental Hematology & Oncology|May 6, 2017
Cyclosporine is a potential curative treatment option for advanced thymomaYusuke Isshiki, Hiroaki Tanaka, Yoshio Suzuki, et al.
Leukemia & Lymphoma|August 27, 2015
Autoimmune thyroid dysfunction after allogeneic hematopoietic stem cell transplantYusuke Isshiki, Keiko Ono, Katsuhiro Shono, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 6, 2023
[Identification of transcriptional features and surface markers of plasma cell clones in POEMS syndrome by single-cell RNA sequencing]Yusuke Isshiki, Motohiko Oshima, Naoya Mimura, et al.
Frontiers in Cell and Developmental Biology|January 24, 2022
Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination TherapiesInna Serganova, Sanjukta Chakraborty, Samuel Yamshon, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 2021
[A Case Report of Cancer Chemotherapy for Disseminated Carcinomatosis of the Bone Marrow Associated with Gastric Cancer Accompanied by Disseminated Intravascular Coagulation]Ryotaro Eto, Satoshi Ambiru, Hiroyuki Yoshidome, et al.
Japanese Journal of Clinical Oncology|October 4, 2017
CD20 positivity and white blood cell count predict treatment outcomes in Philadelphia chromosome-negative acute lymphoblastic leukemia patients ineligible for pediatric-inspired chemotherapyYusuke Isshiki, Chikako Ohwada, Emiko Sakaida, et al.
Blood Advances|September 1, 2019
KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesisYusuke Isshiki, Yaeko Nakajima-Takagi, Motohiko Oshima, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Cancer Drug Targets|January 8, 2021
Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL)Yusuke Isshiki, Ari Melnick
Experimental Hematology|December 18, 2018
Emerging role of noncanonical polycomb repressive complexes in normal and malignant hematopoiesisYusuke Isshiki, Atsushi Iwama
BMJ Case Reports|December 21, 2018
Multiple cystic lung lesions and autoimmune thrombocytopaenia developing after chemotherapy for pulmonary indolent B-cell lymphoma with plasmacytic differentiationHiroaki Tanaka, Chihiro Kuwabara, Yusuke Isshiki, et al.
Experimental Hematology & Oncology|May 6, 2017
Cyclosporine is a potential curative treatment option for advanced thymomaYusuke Isshiki, Hiroaki Tanaka, Yoshio Suzuki, et al.
Leukemia & Lymphoma|August 27, 2015
Autoimmune thyroid dysfunction after allogeneic hematopoietic stem cell transplantYusuke Isshiki, Keiko Ono, Katsuhiro Shono, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 6, 2023
[Identification of transcriptional features and surface markers of plasma cell clones in POEMS syndrome by single-cell RNA sequencing]Yusuke Isshiki, Motohiko Oshima, Naoya Mimura, et al.
Frontiers in Cell and Developmental Biology|January 24, 2022
Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination TherapiesInna Serganova, Sanjukta Chakraborty, Samuel Yamshon, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 2021
[A Case Report of Cancer Chemotherapy for Disseminated Carcinomatosis of the Bone Marrow Associated with Gastric Cancer Accompanied by Disseminated Intravascular Coagulation]Ryotaro Eto, Satoshi Ambiru, Hiroyuki Yoshidome, et al.
Japanese Journal of Clinical Oncology|October 4, 2017
CD20 positivity and white blood cell count predict treatment outcomes in Philadelphia chromosome-negative acute lymphoblastic leukemia patients ineligible for pediatric-inspired chemotherapyYusuke Isshiki, Chikako Ohwada, Emiko Sakaida, et al.
Blood Advances|September 1, 2019
KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesisYusuke Isshiki, Yaeko Nakajima-Takagi, Motohiko Oshima, et al.
Pageof 4